Ligand Pharmaceuticals
D

LGND

306.02
USD
7.02
(2.35%)
بعد الجلسة·306.22USD+0.20(+0.07%)
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
3,888
الربح لكل سهم
9
العائد الربحي
-
P/E
123
حجم السوق
6,121,313,776
أصول ذات صلة

العنوان: Ligand Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license andmilestone payments, and sale of its trademarked Captisol material.

أسئلة شائعة حول سهم Ligand Pharmaceuticals